A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)

NCT01334203 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Angina Pectoris
Coronary Artery Disease
Type 2 Diabetes Mellitus

Interventions

DRUG: Ranolazine

Sponsor

Gilead Sciences